NCT01968239View on ClinicalTrials.gov

Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 17, 2016

Study Completion Date

December 20, 2016

Conditions
Branch Retinal Vein Occlusion
Interventions
DRUG

Ranibizumab

comparison of different re-treatment criteria for intravitreal injection of ranibizumab

Trial Locations (1)

04103

Department of Ophthalmology, University Leipzig, Leipzig

All Listed Sponsors
lead

University of Leipzig

OTHER

NCT01968239 - Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT | Biotech Hunter | Biotech Hunter